CME precious metals stocks soar on Trump tariff threat
Gold stocks in COMEX-approved warehouses have jumped by one-third in the past six weeks.
(via TheNewswire)
Vancouver, BC, January 17, 2025 – TheNewswire – TAAT Global Alternatives, Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT”) is pleased to announce the signing of a non-binding Letter of Intent dated January 17, 2025 (the “LOI”) to acquire Premium Products LLC (“Premium Products”), an emerging distributor in the alternative product space. This acquisition aligns with TAAT’s strategic objectives to diversify its product offerings, tap into new market opportunities, and accelerate revenue growth within the consumer-packaged goods (CPG) sector.
Strategic Rationale for the Acquisition
The acquisition of Premium Products represents a significant step forward in TAAT’s mission to innovate and disrupt the alternative product industry. Premium Products have a diverse product portfolio through its Delta-9 offerings which include chocolates, gummies, and disposable vape devices. Premium Products have also developed partnerships to bring other innovative products to market, including non-tobacco nicotine alternatives and wellness-focused beverages, reinforcing its position in the alternative product space.
Transaction terms
The agreed acquisition price pursuant to the LOI is CAD $1,850,000, which is to be distributed as 10,882,353 common shares of TAAT, issued at a deemed price of $0.17 per share to the members of Premium Products. Key personnel of Premium Products will continue to support TAAT post-acquisition to ensure a smooth integration into TAAT's business. The common shares issuable to the vendor in connection with the acquisition will be subject to a four-month-and-one-day hold period from the date of issue pursuant to National Instrument 45-106 (Prospectus Exemptions). The Company does not anticipate that there will be any finders’ fees payable on this transaction, nor will there be a change of control or any new control persons created. Premium Products is an arm’s length party to the Company.
The acquisition is subject to receipt of all necessary regulatory approvals, including, as applicable, all required filings with the Canadian Securities Exchange, completion of due diligence reasonable or customary in a transaction of a similar nature, and entering into a definitive agreement. The acquisition will not constitute a fundamental change, within the meaning of the policies of the CSE.
TAAT’s Continued Organic Growth
TAAT continues to experience demand for its Beyond Tobacco™ cigarettes, which provide a nicotine- and tobacco-free smoking experience. This trend reflects broader consumer preferences for wellness-focused alternatives, particularly among adult smokers seeking healthier options. The acquisition enhances TAAT’s ability to deliver a broader range of alternative products to meet evolving consumer demands.
On behalf of the Board of Directors of the Company,
TAAT® GLOBAL ALTERNATIVES INC.
“Joel Dumaresq”
Joel Dumaresq, CFO and Director
For further information, please contact:
TAAT® Investor Relations
1-604-687-2038
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.
About TAAT Global Alternatives, Inc.
TAAT is a consumer product company specializing in innovative alternatives to traditional CPG categories. With a commitment to quality and consumer satisfaction, TAAT operates from its Ohio distribution center, fulfilling orders and supporting a growing network of retail locations across the U.S.
For additional information, visit taatglobal.com
Forward-Looking Statements
Certain information contained herein may constitute "forward-looking information" or "forward-looking statements" under Canadian securities legislation. Generally, forward-looking information can be identified by words such as "pro forma", "plans", "expects", "may", "should", "could", "will", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", or variations including negative variations thereof of such words and phrases that refer to certain actions, events or results that may, occur or be taken or achieved. Such forward-looking statements, including but not limited to statements relating to the expected development and operations of the Company, including market conditions, regulatory developments and the successful integration and performance of Premium Products LLC within TAAT’s broader operations which involve risks, uncertainties and other factors which may cause the actual results to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Corporation will not update any forward-looking statements or forward-looking information included herein, except as required by applicable securities laws.
The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease.
This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by the Company with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with the Company is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees.
Statement Regarding Third-Party Investor Relations Firms
Disclosures relating to investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the Company's profile on www.sedarplus.ca.
Copyright (c) 2025 TheNewswire - All rights reserved.
